| "Epidural Spinal Cord Stimulation: Addressing Spasticity and Motor Function" (NCT05422716) | Kessler Foundation | 2022-07-14 |
| Phase II Study to Assess Safety, Pharmacokinetics and Efficacy of SL-1002 for Limb Spasticity (NCT05311215) | Saol Therapeutics Inc | 2022-04-22 |
| Ultrasonograpy in Hemiplegic Patients (NCT06706063) | Afyonkarahisar Health Sciences University | 2022-04-15 |
| Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity (NCT04815967) | Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC | 2021-11-02 |
| A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity. (NCT04752774) | Ipsen | 2021-04-29 |
| Retrospective Real-Life Study From One Brazilian Reference Center Assessing Long-Term Experience In The Treatment Of Adult Spasticity With AbobotulinumtoxinA (NCT04446702) | Ipsen | 2021-03-05 |
| Neuroimmunology Registry and Biobank (NCT06958341) | Charite University, Berlin, Germany | 2021-02-01 |
| Study Assessing Adult Subjects Affected With Upper and/or Lower Limb Spasticity Treated With Botulinum Neurotoxin Type A (NCT04340336) | Ipsen | 2020-07-21 |
| Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Lower Limb Spasticity (NCT04099667) | Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC | 2019-12-17 |
| miR-142-3p as Potential Biomarker of Synaptopathy in MS (NCT03999788) | Neuromed IRCCS | 2019-12-10 |
| CLINICAL EFFECT OF BOTULINUM TOXIN TYPE A IN TREATMENT OF SPASTICITY (NCT04673240) | Università degli Studi del Piemonte Orientale Amedeo Avogadro | 2019-03-29 |
| Neuromusculoskeletal Modeling of Muscle Spasticity (NCT05447299) | Region Stockholm | 2019-01-15 |
| Dry Needling and Bobath Treatment Clinical Effects Focused on Stroke Patients (NCT03906305) | Universidad Rey Juan Carlos | 2018-11-26 |
| Effectiveness of Dry Needling (DNHS Technique) in Patients With Chronic Stroke (NCT03546517) | Universidad San Jorge | 2018-06-19 |
| Imaging of 3D Innervation Zone Distribution in Spastic Muscles From High-density Surface EMG Recordings (NCT03302741) | The University of Texas Health Science Center, Houston | 2017-11-21 |
| Spinal Cord Stimulation to Augment Activity Based Therapy (NCT03240601) | Shepherd Center, Atlanta GA | 2017-07-01 |
| Modulation of H-reflex After Application of Electric Currents in Healthy People (NCT02718989) | University of Castilla-La Mancha | 2017-06-01 |
| Comparing the Effect of Focused and Radial Extracorporeal Shock Waves on Post-stroke Hypertonia (NCT03129529) | Mackay Memorial Hospital | 2016-01-01 |
| Developing and Testing a Comprehensive MS Spasticity Management Program (NCT02170779) | VA Office of Research and Development | 2015-10-01 |
| The Effects of Cannabis on Dystonia and Spasticity on Pediatric Patients (NCT02470325) | Wolfson Medical Center | 2015-07-01 |
| Study on the Use of Botulinum Toxin Type A in the Treatment of Chronic Post-stroke Spastic Patients (NCT02390206) | Ipsen | 2015-06-01 |
| Importance of the Current Density in TENS (NCT02718690) | University of Castilla-La Mancha | 2014-12-01 |
| Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment of Post-Stroke Spasticity (NCT02268461) | University of Minnesota | 2014-12-01 |
| Effects of DNHS Technique in the Treatment of Upper Limb Spasticity and Function in Stroke (NCT02291159) | Universidad San Jorge | 2014-11-01 |
| Functional MRI and DTI in the Preoperative Assessment of Dystonia (NCT02877836) | University Hospital, Montpellier | 2014-09-19 |
| Shockwaves Therapy and Botulinum Toxin for the Treatment of Spasticity in Patients With Cerebral Palsy. A Cross Over RCT (NCT02400619) | Xavi Vidal Novellas | 2014-09-01 |
| The Effect of Extracorporeal Shock Wave Therapy on Spasticity (NCT02221011) | Tri-Service General Hospital (TSGH) | 2014-08-01 |
| Extracorporeal Shock Wave Therapy (ESWT) for the Treatment of Spasticity in Persons With Spinal Cord Injury (NCT02203994) | Swiss Paraplegic Research, Nottwil | 2014-07-01 |
| ETREAT Study on Effectiveness of Botulinum Toxin Type A Injections to Treat Post-stroke Upper and/or Lower Limb Spasticity (NCT02275312) | Ipsen | 2014-07-01 |
| Study of SPARC1103 in Subjects With Spasticity (NCT02027025) | Sun Pharma Advanced Research Company Limited | 2014-04-21 |
| The Effect of Whole Body Vibration on Spasticity in Persons With Spinal Cord Injury (NCT02127606) | Kessler Foundation | 2014-04-01 |
| Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Arm(s) or of Arm(s) and Leg(s) in Cerebral Palsy (NCT02002884) | Merz Pharmaceuticals GmbH | 2014-03-28 |
| Rectus Femoris Tenotomy Versus Botulinum Toxin A for Stiff Knee Gait After Stroke (NCT02114736) | University Hospital of Mont-Godinne | 2014-03-01 |
| Upper Extremity Rehabilitation Using Robot and Botulinum Toxin (NCT02228863) | National Rehabilitation Center, Seoul, Korea | 2014-03-01 |
| A Randomized, Double Blind, Multi-center, Active Drug Controlled, Phase III Clinical Trial to Compare the Safety and Efficacy of DWP450 Versus Botox® in Treatment of Post Stroke Upper Limb Spasticity (NCT01945684) | Daewoong Pharmaceutical Co. LTD. | 2013-09-01 |
| Phase III Study of Botulax® to Treat Post Stroke Upper Limb Spasticity (NCT01915459) | Hugel | 2013-06-01 |
| Safety Study of SPARC1104 (NCT01797185) | Sun Pharma Advanced Research Company Limited | 2013-04-09 |
| Reliability of an Algorithm to Diagnose Spasticity (NCT01644123) | Vanderbilt University | 2013-04-01 |
| One Year, Open Label, Dose Escalation Long-term Safety Study in Multiple Sclerosis (MS) Subjects With Spasticity (NCT01844232) | RVL Pharmaceuticals, Inc. | 2013-04-01 |
| A Study to Define the ECG Effects of Tizanidine Compared to Placebo and the Positive Control, Moxifloxacin, in Healthy Men and Women Using a Blinded ECG Evaluator: A Thorough ECG Trial (NCT01839279) | Acorda Therapeutics | 2013-04-01 |
| Efficacy and Safety of SPARC0921 in Subjects With Spasticity (NCT01457352) | Sun Pharma Advanced Research Company Limited | 2012-11-14 |
| Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis (NCT01743651) | RVL Pharmaceuticals, Inc. | 2012-11-01 |
| Long-term Surveillance of the MedStream Programmable Infusion System (NCT01712087) | Codman & Shurtleff | 2012-10-01 |
| Surface EMG Biofeedback for Children With Cerebral Palsy (NCT01681888) | University of Southern California | 2012-05-01 |
| Use of Ultrasound in Injections of Botulinum Toxin (NCT02566837) | University Hospital, Toulouse | 2012-02-01 |
| A Randomized Study of Sativex on Cognitive Function and Mood: Multiple Sclerosis Patients (NCT01964547) | Jazz Pharmaceuticals | 2012-01-01 |
| DTI Study of the Influence of Physiotherapy on Distribution of BoNT in Spastic Muscle (NCT01523210) | Kirsten Elwischger, MD | 2011-11-01 |
| Adult Subjects Suffering From Lower Limb Spasticity Following Stroke (NCT01444794) | Ipsen | 2011-09-01 |
| MEDITOXIN® Versus BOTOX® in the Treatment of Post-stroke Spasticity of the Upper Limb Spasticity (NCT01313767) | Medy-Tox | 2011-03-01 |
| A Prospective Study of Spasticity in Individuals With Multiple Sclerosis (NCT01111435) | Fraser, Cira, Ph.D., RN, ACNS-BC | 2010-04-01 |
| Continuous Intrathecal Baclofen Infusion for Chronic Spasticity (NCT01051128) | Flowonix Medical | 2010-01-01 |
| Neuro-orthopaedic Surgery in the Treatment of the Spastic Equinovarus Foot (NCT01265238) | University Hospital of Mont-Godinne | 2009-12-01 |
| Kinesiotaping the Hand in Cerebral Palsy (NCT02073513) | Hacettepe University | 2009-11-01 |
| A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis (NCT00914290) | Impax Laboratories, LLC | 2009-04-01 |
| Trial Comparing Two Commercial Formulations of Botulinum Toxin Type A in the Treatment of Spasticity (NCT00819065) | Hospital de Clinicas de Porto Alegre | 2009-03-01 |
| Early Injection of Botulinum Toxin on Motor Function and Gait Pattern in Stroke Patients (NCT01817816) | Changhua Christian Hospital | 2009-01-01 |
| Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity (NCT00607542) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2008-11-01 |
| Energy Costs of Spasticity in Spinal Cord Injury: A Pilot Investigation (NCT00572845) | Virginia Commonwealth University | 2008-01-01 |
| One Year Extension Study To Protocol C2/5/TZ:MS-05 (NCT00464958) | Teva GTC | 2008-01-01 |
| A Study of the Safety and Effectiveness of Sativex®, for the Relief of Symptoms of Spasticity in Subjects, From Phase B, With Multiple Sclerosis (MS) (NCT00681538) | Jazz Pharmaceuticals | 2008-01-01 |
| Evaluate the Maintenance of Effect After Long-term Treatment With Sativex® in Subjects With Symptoms of Spasticity Due to Multiple Sclerosis (NCT00702468) | Jazz Pharmaceuticals | 2007-11-01 |
| Use of EMG to Assess Clinical Hypertonia (NCT00472914) | University of Southern California | 2007-01-01 |
| Validation of an Obstacle Course Used in Patients With Muscle Tightness (NCT00776048) | Kessler Foundation | 2007-01-01 |
| Power Wheelchair Joystick Use in Spastic Cerebral Palsy (NCT00337688) | University of Pittsburgh | 2006-07-01 |
| Botox vs. Baclofen for Upper Limb Spasticity (NCT00280280) | Vanderbilt University | 2006-02-01 |
| Optical Stimulation in Peripheral Nerves for Select Rhizotomy Procedures (NCT00575536) | Vanderbilt University | 2006-01-01 |
| Vanderbilt University Spasticity Management Program Evaluation Plan (NCT00179114) | Vanderbilt University | 2002-08-01 |
| A Study of Sativex® for Relief of Spasticity in Subjects With Multiple Sclerosis. (NCT00711646) | Jazz Pharmaceuticals | 2002-06-01 |
| A Study of the Long-term Safety of Sativex Use (NCT01606137) | Jazz Pharmaceuticals | 2002-02-01 |
| Dutch National ITB Study in Children With Cerebral Palsy (NCT00367068) | Maastricht University | 2002-01-01 |
| Comparative Efficacy of Three Preparations of Botox-A in Treating Spasticity (NCT00178646) | The University of Texas Health Science Center, Houston | 2002-01-01 |
| A Long-term Safety Extension Study of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis (NCT01610687) | Jazz Pharmaceuticals | 2001-07-01 |
| Phase 3, 28-week, Randomized, Double-blind, Placebo-controlled Safety and Efficacy Study of Nabiximols as an add-on Therapy in Subjects With Spasticity Due to Multiple Sclerosis. (NCT01868048) | GW Research Ltd | |